Term
Intermittent Allergic Rhinitis (IAR) |
|
Definition
Symptoms ≤ 4 days/week or ≤4 weeks |
|
|
Term
Persistent Allergic Rhinitis (PER) |
|
Definition
Symptoms >4 days/week and >4 weeks |
|
|
Term
Mild severity symptoms of allergic rhinitis |
|
Definition
Do not impair sleep or daily activities no troublesome symptoms |
|
|
Term
Moderate-Severe symptoms of allergic rhinitis |
|
Definition
Sleep disturbance, impaired daily activities (work, school) |
|
|
Term
Allergic Rhinitis exclusions for self-treatment |
|
Definition
-Children<12 years -Pregnant or lactating women -Non-allergic rhinitis -Otitis media, sinusitis, bronchitis, or other infection -Undiagnosed or uncontrolled asthma (wheezing, SOB), COPD or other lower respiratory disorder -Severe or unacceptable side effects of treatment |
|
|
Term
Non-allergic rhinitis causes |
|
Definition
-hormonal: pregnancy, puberty, thyroid disorders -structural: septal deviation , adenoid hypertrophy -drug-induced: cocaine, beta-blockers, ACEIs, chlorpromazine, clonidine, reserpine, hydralazine, oral contraceptives, aspirin or other topical decongestants -Systemic Inflammatory: eosinophilic nonallergic rhinitis (NARES) -Lesions: nasal polyps, neoplasms -Traumatic: recent facial or head trauma -autonomic: age-related, physical or chemical agent causes |
|
|
Term
Symptoms of allergic rhinitis |
|
Definition
-bilateral, worst in the a.m. improve during the day, worsen in the p.m. -frequent sneezing, paroxysmal -sneezing anterior, watery -variable nasal obstruction -frequent conjunctivitis -sinus pain due to congestion, throat pain due to postnasal drip -anosmia: loss of sense of smell is rare -epistaxis is rare -facial, nasal or throat features: allergic shiners, Dennie's lines, allergic crease, allergic salute, allergic gape, non-exudative cobblestone appearance of posterior oropharynx |
|
|
Term
Symptoms of non-allergic rhinitis |
|
Definition
-unilateral common, can be bilateral, constant day/night -little or none -rhinorrhea: posterior, watery, thick and/or mucopurulent -nasal obstruction is often present, often severe -pain is variable depending on the cause -anosmia: loss of sense of smell is frequent -epistaxis is recurrent -facial, nasal or throat features: nasal polyps, nasal septal deviation, enlarged tonsils and/or adenoids |
|
|
Term
Treatment of allergic rhinitis |
|
Definition
-sequential: allergen avoidance, pharmacotherapy, and allergen immunotherapy -intranasal corticosteroids are the most effective: beclomethasone, budesonide, fluticasone, or triamcinolone -antihistamine are commonly used, but less effective: non-sedating antihistamines are preferred over sedating based on efficacy and safety |
|
|
Term
|
Definition
-check local pollen counts and air quality index -keep windows shut -avoid yard work/outdoor sports with high pollen -remove triggers (i.e. cats, dust mites, tobacco smoke, mold) -lower humidity to reduce molds (ie: vent kitchen and bathrooms) -remove house plants -wash bedding (130F) weekly, encase mattresses and pillows in coverings resistant to dust mites |
|
|
Term
Intranasal Corticosteroids (INCS) |
|
Definition
-Budensonide (Rhinocort Allergy): >6 years -Fluticasone (Flonase Allergy Relief): >4 years -Triamcinolone (Nasacort Allergy 24 hour) >2 years -may take 1 week to control symptoms -shake before use |
|
|
Term
|
Definition
-Alkylamines -Ethanolamines -Phenothiazines -piperidines -piperazines |
|
|
Term
|
Definition
Moderately sedating, strong anticholinergic effects, higher risk of paradoxical CNS stimulation compared with other classes. -brompheniramine -chlorpheniramine -dexbrompheniramine -dexchlorpheniramine -pheniramine -triprolidine |
|
|
Term
|
Definition
Highly sedating, strong anticholinergic effects, large doses cause seizures and arrhythmias -clemasine -diphenhydramine -doxylamine |
|
|
Term
|
Definition
Weak CNS effects, increase GI effects -pyrilamine -tripelennamine -thonzylamine |
|
|
Term
|
Definition
Highly sedating, strong anticholinergic effects, block alpha-adrenergic receptors, more likely to cause hypotension, akathisia and dystonic reactions may occur -promethazine |
|
|
Term
|
Definition
Non-sedating -fexofenadine -loratadine -phenindamine |
|
|
Term
|
Definition
Minimally to moderately sedating -cetirizine -chlorcyclizine -hydroxyzine -levocetirizine -meclizine |
|
|
Term
|
Definition
-common with allergic rhinitis -can treat with systemic decongestants or short term ≤5 days of topical nasal decongestants -effective for congestion, but litle effect on other symptoms |
|
|
Term
Nasal Cromolyn (NasalCrom) |
|
Definition
-prevents allergic rhinitis --> use before exposure-stabilizes mast cells --> initial effect 3-7 days, maximum effect 2-4 weeks -less effective than intranasal corticosteroids -simiar efficacy to antihistamines -more effective than placebo -ADRs: sneezing, brief nasal burning or stinging, nose bleeds, wheezing -≤2 years of age |
|
|
Term
When to seek medical attention regarding allergic rhinits |
|
Definition
-symptoms worsen on OTC medication -no improvement in 2-4 weeks of treatment -secondary bacterial infection: --> non-clear, thick nasal or respiratory secretions --> temperature > 101.5F --> SOB --> Chest congestion --> wheezing --> ear pain --> rash |
|
|
Term
Allergic rhinitis conjunctivitis |
|
Definition
-oral antihistamines -intraocular antihistamines -saline |
|
|
Term
Nasal corticosteroids: Budesonide, fluticasone, triamcinalone (nasal) allergic effects in pregnancy |
|
Definition
-facial clefts in some studies |
|
|
Term
Piperazines and Piperadine allergic effects in pregnancy |
|
Definition
-not expected to increase the risk of malformations |
|
|
Term
Nasal corticosteroids: Budesonide, fluticasone, triamcinalone (nasal) allergic effects on lactation |
|
Definition
-infant exposure expected to be minimal -considered compatible with breastfeeding |
|
|
Term
Fexofenadine effects on lactation |
|
Definition
-lack of sedation and low milk levels--> no expected to cause any adverse effects in breastfed infants -might have a negative effect on lactation |
|
|
Term
Cetirizine effects on lactation |
|
Definition
-Small occasional doses of cetirizine are probably acceptable in breastfeeding -larger doses/prolonged use= may cause drowsiness and other effects in the infant or decrease the milk supply |
|
|
Term
Loratadine effects on lactation |
|
Definition
-lack of sedation and low milk levels--> no expected to cause any adverse effects in breastfed infants -might have a negative effect on lactation |
|
|
Term
Issues with drugs in pregnancy |
|
Definition
-49% of pregnancies are unintended -women listen to the negative effects of drugs that are not harmful (25% increase) -Underying illness associated with maternal, fetal and neonatal morbidity and mortality -PK and PD are altered in pregnancy -Timing of exposure matters |
|
|
Term
|
Definition
-pregnancy including labor and delivery -lactation including nursing mothers -female and male reproductive potential |
|
|
Term
Normal pregnancy duration |
|
Definition
37-42 weeks, average is 40 weeks |
|
|
Term
Embryonic/fetal development stages |
|
Definition
1. Zygote 2. bilaminar embryo 3. embryonic period 4. fetal period |
|
|
Term
Most organs have developed in the fetus after __weeks |
|
Definition
|
|
Term
|
Definition
Increased: CYP3A, CYP2C9, CYP2D6, UGT, P-gp, OCT2, CrCl Decreased: CYP1A2, possibly CYP2C19 |
|
|
Term
Good references for drug toxicity during pregnancy |
|
Definition
-Drugs in pregnancy and lactation (Briggs) -Reprotox -Teris -Product label if updated drug, if not, the label is not useful |
|
|
Term
Drugs that should not be given during pregnancy |
|
Definition
1. Thalidomide (25% major malformations) 2. Isotretinoin (50% major human teratogen)--wait one month before trying to get pregnant 3. Mycophenolate (Immunosuppressant for transplant patients) (27% malformations in patients): microtia (small head), cleft lip and palate, hypoplastic nails, shortened fingers, external auditory duct atresia, diaphragmatic hernias, heart malformations |
|
|
Term
Malformation risk_______ when underlying conditions are uncontrolled |
|
Definition
|
|
Term
|
Definition
Long term complications -higher rate of impaired glucose tolerance at 2-5 years -higher rate of type 2 diabetes -higher rate of metabolic syndrome -childhood obesity |
|
|
Term
Should sertraline be used in pregnancy? |
|
Definition
-Yes--does not adversely affect outcome. Depression should be treated! -has risk of neonatal pulmonary hypertension in some studies -has risk if reuptook late in pregnancy: of mild transient neonatal syndrome of CNS, motor, respioratory, and GI signs |
|
|
Term
Benefits of breastfeeding |
|
Definition
-maternal-neonatal bonding -uterine contraction and decreased risk of bleeding -increased IQ in offspring (possibly) -complete nutrition for 1st 6 months, except possibly vitamin D -Less odor from neonatal bowel movements -decreased cost |
|
|
Term
Breastfeeding prevents/reduces risk of |
|
Definition
-middle ear infections -respiratory tract infections -colds and infections -gut infections -intestinal tissue damage -sudden infant death syndrome -allergic diseases -celiac disease -IBD -Diabetes -childhood leukemia |
|
|
Term
3 methods of drug transfer into breast milk |
|
Definition
1. Closed junction transcellular diffusion 2. Open junction paracellular diffusion 3. Milk fat paracellular diffusion |
|
|
Term
Breast milk and maternal plasma pH |
|
Definition
-breast milk: 7.0 -maternal plasma: 7.4 |
|
|
Term
Factors that influence movement of drugs to breast milk |
|
Definition
-maternal plasma level the higher the plasma level, the higher the breast milk concentration -Protein binding: only unbound drug crosses, lower protein concentration in milk -lipid solubility: more likely to cross -acid/base: weak bases transfer to acidic milk and then are trapped -MW: higher MW (than 800Da--like insulin or heparin) are too large to cross the alveolar acini (glandular tissue where milk is produced) |
|
|
Term
Factors in infant toxicity in breast feeding |
|
Definition
-the dose in breast milk relative to the therapeutic amount -the amount absorbed by a nursing infant -the infant's ability to clear the drug |
|
|
Term
Relative infant dose (RID) calculation |
|
Definition
Infant dose (mg/kg/day)/maternal dose(mg/kg/day) -RID is usually safe under 10% |
|
|
Term
|
Definition
-24-48hours -teaspoons -low in fat -high in carbs, protein and secretory IgA |
|
|
Term
|
Definition
-beginning of feeding -oz -low in fat -high in volume |
|
|
Term
|
Definition
-end of feeding -higher in fat |
|
|
Term
Different drugs are absorbed differently in different milks in the breastfeeding process: T or F? |
|
Definition
True, sampling data is not easily correlated with this due to the collection of samples being at different stages of the feeding process. |
|
|
Term
Best resource for medication safety during lactation |
|
Definition
|
|
Term
Is codeine safe during lactation? |
|
Definition
NO!!! Even though RID is <1.4% (less than 10) -codeine is a precursor of morphine--2005 baby died of morphine toxicity |
|
|
Term
Is it okay for lactating mothers to give wait a few hours after taking their medication to nurse to avoid drug meeting the maximum concentration that could be passed on to the infant? |
|
Definition
-No, peak concetrations of drug can be met 2 hours after taking the drug! The peak is unpredictable! -Also note that outliers in RIDs may be above the 10% cut-off, but are still safer when considering that the infant plasma levels measured are usually lower |
|
|
Term
Infant age affects the types of metabolizing enzymes present? T or F? |
|
Definition
True, CYP450 for example is only present for about 24 hours and other enzymes develop thereafter with organ development= this changes the ability to metabolize drugs! |
|
|
Term
Can sertraline be taken during lactation? |
|
Definition
-Yes, little risk of withdrawal effects when some is lost in breastmilk -since the baby has already been exposed, they have a lower risk of poor neonatal adaptation than if they were not exposed |
|
|